Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 125

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1C
Chunk 125
---
 price. In addition, the fair value of assets and liabilities should include consideration of non-performance
risk, which for the liabilities described below includes the Company’s own credit risk.

As
a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the
valuation methodologies in measuring fair value:

    Level
    1 -
    Valuations
    based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and
    block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly
    available in an active market, valuation of these products does not entail a significant degree of judgment.

    Level
    2 -
    Valuations
    based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly
    or indirectly.

    Level
    3 -
    Valuations
    based on inputs that are unobservable and significant to the overall fair value measurement.

The
Company holds shares in iMine Corporation (“iMine”) formerly known as Diamante Minerals, Inc., a publicly-traded
company on the OTCQB.

Due
to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price
for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the
effect of the sales restrictions and is therefore, ranked as Level 2 asset.

o.
Basic and diluted net loss per share:

Basic
net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. Diluted net
income per share is computed based on the weighted average number of shares of common stock outstanding during each year plus dilutive
potential equivalent common stock considered outstanding during the year, in accordance with ASC 260, “Earnings per Share”.
For the years ended December 31, 2024 and 2023, all outstanding options and warrants have been excluded from the calculation of the diluted
net loss per share since their effect was anti-dilutive.

p.
Concentrations of credit risk:

Financial
instruments that potentially subject the Company and its subsidiaries to concentrations of credit risk consist principally of cash and
cash equivalents.

Cash
and cash equivalents are invested in banks in Israel, Spain and United States. Such deposits in